Jasper Therapeutics, Inc.

Develops mast cell-depleting antibody therapies for chronic diseases and stem cell transplants.

JSPR | US

Overview

Corporate Details

ISIN(s):: US4718712023 (+3 more)
LEI:
Country:: United States of America
Address:: 2200 BRIDGE PKWY SUITE #102, 94065 REDWOOD CITY
Website:: https://jaspertx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for mast cell-driven diseases and as a conditioning agent for hematopoietic stem cell transplantation. The company's lead product candidate is briquilimab, a targeted anti-KIT (CD117) monoclonal antibody designed to deplete mast cells. Jasper is evaluating briquilimab in clinical studies for the treatment of chronic immunological and inflammatory diseases, including chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma. The company's mission is to develop safer and more effective therapies for patients with serious chronic diseases by harnessing the power of mast cell depletion.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Jasper Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Jasper Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Jasper Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
MARAVAI LIFESCIENCES HOLDINGS, INC. Provides nucleic acid products and biologics safety testing for new therapies and vaccines.	United States of America	MRVI
Marinomed Biotech AG Develops virus-blocking products & immunology therapies via proprietary technology platforms.	Austria	MARI
Marker Therapeutics, Inc. Developing non-genetically modified T cell immunotherapies for hematologic and solid tumors.	United States of America	MRKR
Matinas BioPharma Holdings, Inc. Developing oral drugs via a lipid nano-crystal platform for infections, oncology & inflammation.	United States of America	MTNB
Matricelf Ltd. Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.	Israel	MTLF
Maze Therapeutics, Inc. Develops genetic precision medicines for common diseases, with a focus on chronic kidney disease.	United States of America	MAZE
MBX Biosciences, Inc. Developing novel peptide therapies for underserved endocrine and metabolic disorders.	United States of America	MBX
MDxHealth SA Provides actionable molecular diagnostics for urologic diseases, specializing in prostate cancer.	United States of America	MDXH
Median Diagnostics Inc. Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.	South Korea	233250
MediciNova,Inc. Developing small-molecule drugs for neurology, respiratory, and liver diseases.	Japan	4875